Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

SETB. 2016; 50(1): 80-3


Treatment of serous maculopathy associated with optic disc pit without vitrectomy: a case presentation

Mehmet Demir, Dilek Guven, Zeynep Acar, Erdem Ergen.




Abstract

Objective: To report an serous maculopathy associated with optic disc pit which was treated with gas injection and laser photocoagulation.
Case: A 21-year-old female was admitted with blurred vision in the left eye. Optic disc pit was detected in the left eye. Best corrected visual acuity (BCVA) was 20/400 (Snellen), central macular thickness (CMT) was 768 µm and intraocular pressure was 15 mmHg in the left eye. Right eye was normal. After corneal paracentesis, 0.3 ml perfluoropropane (C3F8) gas was injected into vitreous cavity and the patient was advised to assume facedown position for 3 days. Laser photocoagulation was performed on the temporal side of the optic disc. Topical brinzolamide 1 % and topical ketorolac tromethamine were used 2x1/day for 3 months after gas injection. At 36th month BCVA was 20/40, CMT reduced. No change in intraocular pressure was observed during follow up.
Conclusion: Perfluoropropane injection and laser photocoagulation with topical medication were effective and safe for serous maculopathy associated with optic disc pit.

Key words: Intravitreal gas, laser, optic disc pit, serous maculopathy






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.